BRANDI STIFF: Open Payments
NPI 1760875652 · OKLAHOMA CITY, OK. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,697 in 53 payments from 11 companies in 2025. Trend: 2023 $1,030 · 2024 $1,163 · 2025 $1,697
Food & beverage: $1,697
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 14 | $336 |
| Janssen Pharmaceuticals, Inc | 4 | $309 |
| Supernus Pharmaceuticals, Inc. | 8 | $210 |
| ABBVIE INC. | 14 | $179 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $170 |
| Insmed, Inc. | 1 | $155 |
| E.R. Squibb & Sons, L.L.C. | 3 | $142 |
| Teva Pharmaceuticals USA, Inc. | 1 | $124 |
| Axsome Therapeutics, Inc. | 2 | $35 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $19 |
Products named: SPRAVATO, Qelbree, VRAYLAR, CAPLYTA, Arikayce, COBENFY, REXULTI, ABILIFY MAINTENA.
Industry payments across OK — which companies pay providers there.
